about 40% but it may be higher in patients receiving chemotherapy. In lymphosarcoma it is of the order of a fraction of 1 % but in macroglobulinaemia, essential or associated with malignant lymphoma, the incidence is considerably higher. Systemic amyloid is found in one in 375 of patients with carcinoma and in only a single patient among 1,500 'control cases'. Renal carcinoma accounts for one-quarter of all carcinomas associated with systemic amyloid. The other carcinomas originate in a variety of organs.
In myelomatosis, amyloid may be found in the tumour deposits. In Hodgkin's disease and in lymphosarcoma there appears to be greater amyloid deposition in neoplastic tissue than hitherto realized. The carcinomas provide a striking example of topographical association of amyloid and tumour, the two being closely related in six of seven cases.
Systemic amyloidosis associated with malignant disease has received some attention in the recent literature but many of the problems arising from the association remain unsolved. This investigation was undertaken in an attempt to clarify some of the controversial points. We are not concerned here with amyloid deposited purely locally within tumours, a remarkable occurrence in a special type of thyroid carcinoma (Hazard, Hawk, and Crile, 1959) , in pancreatic insulinomas (Porta, Yerry, and Scott, 1962) , and in certain calcifying odontogenic tumours (Vickers, Dahlin, and Gorlin, 1965) .
MATERIAL AND METHODS
This study is based on an analysis of 8,758 necropsies at Hammersmith Hospital between 1935 and 1962 inclusive; neonates up to 1 month old are excluded. The methods used to confirm the presence of amyloid consisted of metachromatic staining with methyl violet, staining with Congo red with resulting birefringence and dichroism, and the demonstration of pale green fluorescence in ultraviolet light after staining with thioflavine-T. Where hyaline collagen gave rise to difficulty, Van Gieson staining and the thioflavine-T method proved invaluable in distinguishing this from amyloid. ' Present address: Guy's Hospital Medical School, London, S.E.I.
RESULTS
There were 93 cases of systemic amyloidosis, a figure that does not include minor degrees of senile (cardiac) amyloidosis. Twenty of these 93 cases were associated with malignant disease but after the clinical and necropsy protocols and the sections had been scrutinized, six cases were excluded because of coexistent disease that was probably or potentially responsible for the development of amyloid. There remain 14 patients in whom assessment of all data led to the conclusion that the malignant disease was responsible for the amyloidosis (Table I ). In 10 of A chest radiograph showed generalized cardiomegaly, and an E.C.G. ventricular extrasystoles with flattened or inverted T waves. Haemoglobin was 10-2 g. %, W.B.C. 8,000/c.mm. The sedimentation rate was 120 mm./hr. Serum uric acid was 9-0 mg. %. Serum protein was 9 3 g. % (albumin 3-3 g. %, globulin 6-0 g. %). Electrophoretic analysis showed a very high narrow peak in the gamma globulin region; ultracentrifugal analysis showed an excess of macroglobulin, calculated to be about 25 Massive amyloid deposits were present in the neoplastic nodes (Fig. 4) , especially striking where sarcomatous nodes invaded muscle. Amyloid was deposited in the myocardium and in adipose tissue (Fig. 6) . Otherwise there was only minimal amyloid in glomeruli and the adrenal capsule.
It could be argued that the suppuration 39 years before the symptomatic onset was the cause of the amyloid, since amyloid can occasionally run a course of a couple of decades or more (McMichael, 1966) . However, significant myocardial infiltration by amyloid remaining clinically silent for over 30 years is highly improbable. The amyloid distribution seen here is relatively uncommon in amyloidosis due to sepsis, and, more cogently, the topographical association of tumour and amyloid supports the view that they are aetiologically related. CASE 8 A man aged 83 complained of weight loss and abdominal swelling and was admitted to hospital in 1961. Marked sacral and leg oedema was present. Pulse was 80/minute, the blood pressure 160/75 mm. Hg. The jugular venous pressure was raised 7 cm. The apex beat was in the sixth intercostal space in the anterior axillary line. An ejection murmur, loudest at the apex and conducted into the neck, was accompanied by a thrill. A hard, nodular liver was palpated. Prostatectomy for hyperplasia had been performed in 1956, and an intravenous pyelogram had shown a large right kidney with calyceal elongation and inadequate filling, appearances considered then to be due to a cyst rather than to a tumour.
Haemoglobin was 9-7 g.%; W.B.C.s numbered 4,000/ c.mm., E.S.R. was 90 mm./hr., blood urea 93 mg.°,0 serum protein 5-1 g.% (albumin 16 g.%, globulin 3 5 g. %); there was gross proteinuria with a loss of 7-5 g. in 24 hours. Chest radiographs showed left ventricular enlargement and pulmonary oedema. Cardiac failure was treated with digoxin, chlorothiazide and potassium supplements, despite which the patient died three months after the onset of symptoms.
Necropsy The right kidney (720 g.) was virtually replaced by a yellow and brown-red tumour, microscopy showing a clear-cell renal carcinoma with necrosis. The left kidney weighed 220 g. In retrospect the pyelographic appearances in 1956 were almost certainly due to renal tumour. The liver (1,865 g.) contained numerous metastases. There was a solitary metastasis in the pancreatic tail and one in the thyroid (58 g.). The spleen (145 g.) showed translucent lymphoid follicles. Tumour had replaced the nodes in the para-aortic, tracheobronchial, and hilar groups. The heart (538 g.) had a hypertrophied left ventricle. The aortic valve showed severe calcific sclerosis leading to a rigid orifice. Both lungs (1,200 g.) were oedematous.
The liver, kidneys, and spleen were affected by amyloidosis. Amyloid was also present in the hypernephroma and in the pancreatic and some nodal metastases (Figs Ackerman, and Maltby, 1955; 6% Kimball, 1961; 15% Kyle and Bayrd, 1961; 19-5 % Snapper, Turner, and Moscovitz, 1953) . Ten per cent. represents a conservative estimate (Table III) . Because amyloid in myelomatosis is often deposited in unusual sites, its presence can escape notice unless it produces obvious clinical signs due to, say, myocardial involvement. Occasionally there is difficulty in distinguishing between myelomatosis with amyloidosis and socalled primary amyloidosis with non-neoplastic plasmacytosis, a difficulty that cannot always be resolved because there is no known clear-cut dividing line between the two conditions (Kyle and Bayrd, 1961) . Four of our 28 cases of myelomatosis had amyloid disease (Figs. 1 and 2) .A fifth case of plasmacell leukaemia, reported elsewhere (Azzopardi, 1962) , had amyloid deposits only in some of the laminated tubular casts of a 'myeloma kidney' (Fig. 3) . Amyloid was also present in the casts of the 'myeloma kidney' in case 5 and in two other 'myeloma kidneys' not in the series. The presence of amyloid in the casts of 'myeloma kidney' has been denied in the past (e.g., Snapper et al., 1953) but our finding not only raises the figure for the incidence of amyloidosis in myeloma but also indicates that myelomatosis is the only disease in which renal casts have been shown to contain amyloid.
In the lymphoma group, Hodgkin's disease is associated with amyloidosis (Wallace, Feldman, Berlin, Harris, and Glass, 1950; Dawson, 1960). The incidence varies in different series (21 % Razis, Diamond, and Craver, 1959; 3 4% Kimball; 8-3 % Castleman, 1949; 18% Cardell, 1961) . Two of our 51 patients with Hodgkin's disease had amyloidosis, an incidence of 4% (Table III) . To explain these differences one must consider the effect of special interest in a particular disease in certain centres and the difficulty of distinguishing hyalinized collagen from amyloid if one relies solely on methyl violet and does not verify the results with thioflavine-T or Van Gieson. The effect of treatment is discussed later. Treatment with nitrogen mustard increases the incidence of amyloidosis in Hodgkin's disease, but it is not the only factor involved since one of the five patients of Razis et al. (1959) had no mustard therapy nor did any of their patients with lymphosarcoma develop amyloid despite mustard treatment. By contrast, the striking effect of therapy in Hodgkin's disease is indicated by Cardell: of eight patients treated with nitrogen mustard or tretamine, four developed amyloid; of 14 not so treated, none developed amyloid. Treatment does not produce this effect merely by prolonging life for, in two of the four patients, albuminuria due to renal amyloid appeared within a few weeks of the therapy. Cardell, borrowing the terminology of experimental cancer workers, regards Hodgkin's as the . initiating factor and therapy as the promoter of amyloid deposition. Since radiotherapy can accelerate the development of amyloidosis (Christensen and Hjort, 1959) , this factor must also be considered. The extensive use of irradiation in Hodgkin's disease does not suggest that its role can be as important as that of the chemotherapeutic agents; large series of untreated controls for comparison are not available.
In Hodgkin's disease amyloid is deposited in the sites usually affected in secondary amyloidosis. Lymph node involvement by amyloid is prominent in some cases, e.g., those of Jackson and Parker. In Castleman's remarkable case amyloid affected mainly the lymph nodes and kidneys; enlarged nodes measuring up to 9 cm. were regarded grossly as being replaced by Hodgkin tissue but microscopy of about 20 nodes showed diffuse replacement by amyloid in all, with minimal residual tumour tissue. In one of our cases there is extensive amyloid in the lymphomatous nodes but little in non-neoplastic nodes. At necropsy there is sometimes little evidence of Hodgkin tissue and death is due to amyloidosis (Jackson and Parker, 1944; Dahlin, 1949 544 group.bmj.com on July 6, 2017 -Published by http://jcp.bmj.com/ Downloaded from se. In an attempt to overcome some of these obstacles, we searched our records and found 2,622 cases of carcinoma and sarcoma, excluding the groups already considered and excluding cases accompanied by a recognized potential cause of amyloidosis. Seven of these 2,622 cases, or one in 375, were accompanied by amyloidosis. One thousand five hundred 'control' cases' were collected. Among these there was a solitary case of amyloidosis (Table  III) . This series of 1,500 needs supplementing by several thousand control cases from other centres.
In six of the seven cases of carcinoma the amyloid distribution is that usually seen in so-called secondary amyloidosis, while in one (case 12) the distribution is that usually seen in so-called primary amyloidosis. Symmers (1956) cautioned against relating a disease, or otherwise, to amyloidosis in a particular patient merely on the distribution of the amyloid deposits, since chronic sepsis can sometimes be associated with amyloid having a 'primary distribution' and, conversely, amyloid with a 'secondary distribution' can occur in the absence of a detectable cause. Bearing these exceptions in mind, the reverse is usually true (Lehner). The argument for a causal relationship between carcinoma and amyloidosis is strengthened if the amyloid has a consistent (and preferably a 'secondary') distribution. For one thing, this would exclude the senile, predominantly cardiac, form of amyloidosis occurring coincidentally with carcinoma.
Ask-Upmark (1940) noted the predominantly secondary type of distribution in amyloidosis with renal malignancy. In our cases of amyloid with renal carcinoma (Table II) and in those reported since Ask-Upmark's review (Table IV) Contrasting with the definite relationship between renal carcinoma and amyloidosis are the isolated reports of carcinomas of uterus, bronchus, stomach, bladder, ovary, biliary tract, etc. associated with amyloid disease (Le Coulant et al., 1961; Dahlin, 1949; Kimball, 1961) . Some of these cases may well be attributable to coincidental primary amyloid, e.g., our case 12 and some of those collected by Le Coulant et al. (1961) . In other instances the secondary type of distribution of the amyloid is suggestive of a causal relationship, though for reasons given before it is impossible to establish or refute a causal relationship merely on the distribution of amyloid. (Figs. 4 and 5) . In our cases of carcinoma associated with amyloidosis, six out of seven show admixture of neoplastic cells and amyloid. This is the more significant as the carcinomas are mixed with amyloid in sites like the uterine cervix, bladder mucosa, and oesophagus where amyloid is relatively infrequent. The transitional-cell carcinoma of the renal pelvis shows this relationship in the renal medulla and in lymph nodes (Fig. 10) . Case 8 shows striking amyloidosis of the sinusoidal vessels in the hypernephroma and case 9 is similar (Figs. 7, 8, and 9) . Even more revealing is the pancreatic metastasis in case 8: the pancreas shows only slight amyloidosis of occasional vessels but in the renal carcinoma metastatic to the pancreas there is heavy deposition of amyloid along the vascular framework of the tumour.
If interference with antibody production plays a role in the pathogenesis of amyloid, one could postulate either that the abnormal protein produced in the reticuloendothelial system is deposited in the carcinoma or else that part of the abnormal protein is formed around the tumour itself as a local response of reticuloendothelial cells. Though we were unable to find evidence of a marked local reticuloendothelial response in our material, this does not exclude its presence at an earlier stage. The pathogenesis of amyloidosis is disputed, but, on either of the two main theories (Teilum, 1964) , deposits of amyloid within carcinomas provide support for the view that the tumour is the aetiological agent responsible.
On the basis of our findings, a diagnosis of amyloidosis can sometimes be made on examining a biopsied or resected carcinoma, an observation only made in retrospect in four patients. In another patient, Hodgkin's disease and amyloid were diagnosed on a node biopsy after the association between these diseases had become apparent. Early diagnosis of amyloid by this means is not simply of academic interest since it can help to clarify diagnostic problems arising postoperatively.
APPENDIX
Because the incidence of amyloidosis in the population is unknown and, in an attempt to establish a baseline for comparison with other diseases, we examined the records of patients with diseases in which there were no grounds for believing that an association with amyloidosis existed and in whom no malignant tumour was present at necropsy or had been previously excised. (Rodent ulcers, solar keratoses, etc., were ignored.) We included patients with myocardial infarction, large myocardial scars believed to represent old infarcts, hypertensive heart disease without a background of glomerulonephritis, pyelonephritis, etc., congenital heart disease, essential malignant hypertension and ischaemic renal hypertension, cerebral vascular accidents including subarachnoid haemorrhage, non-syphilitic aortic aneurysms, severe atheromatous disease leading for instance to mesenteric vascular occlusion or peripheral gangrene, haemorrhage from peptic ulcer, patients with perforated peptic ulcer, strangulated hernia, or non-neoplastic intestinal obstruction dying within four weeks of the acute episode, patients with peptic ulcer dying within four weeks of operation, and cases of violent death only where a thorough necropsy had been carried out. Children under 15 years were excluded to rule out major age differences between the test and the control series. Patients with diabetes mellitus, cirrhosis, glomerulonephritis, collagen disorders, and cor pulmonale were excluded.
One thousand five hundred cases were collected in the period 1935 to June 1961 inclusive; among these 'controls' there was a solitary patient with amyloidosis; this had a 'secondary distribution'. The patient was a 56-year-old man who died of cardiac failure due to hypertensive heart disease. Since he had renal amyloid and this may itself lead to hypertension, this case may represent a 'false positive'. Ideally, hypertensive patients should be excluded from the controls but this would substantially reduce t controls.
